Fund strategy
The Sub-Fund aims at capital appreciation over the medium to long-term while controlling the risks related to the assets classes by investing mainly in a selected portfolio denominated in U.S Dollars of ETFs, ETNs, equities, VIX futures, options on ETFs, options on ETNs, bonds and debt securities and instruments of all types. By analysing implied and historical volatility, the Fund is creating value through different strategies among investing mainly in volatility indices. Whereby the Sub-Fund can also go into short positions of those indices using only derivatives.
Performance
Fees and Expenses
Total Returns
Fund's details
Geographical Distribution
Fund's portfolio distribution among the different geographical areas.
| United States of America | 93,23% | |
| UNITED KINGDOM | 14,96% | |
| GERMANY | 4,12% | |
| DENMARK | 2,33% | |
| IRELAND | 1,67% | |
| CHINA | 1,33% |
By investments
Fund's investments distribution.
| Scpharmaceuticals Inc Ord | 11,59% |
| Verona Pharma Adr | 8,14% |
| Concert Pharmaceuticals Inc Ord | 7,78% |
| Synlogic Inc Ord | 7,72% |
| Protara Therapeutics Inc Ord | 7,38% |
| Astria Therapeutics Inc Ord | 6,88% |
| Atai Life Sciences Nv Ord | 4,12% |
| Olema Pharmaceuticals Inc Ord | 3,79% |
| Nautilus Biotechnology Inc Ord | 3,76% |
| Orchard Therapeutics Plc Dr | 3,68% |
By sector
Fund's possitions distribution by the sdctor they belong to.
| Healthcare | 117,64% |
